tradingkey.logo

Avalon Globocare Corp

ALBT
查看詳細走勢圖
1.260USD
-0.020-1.56%
收盤 12/24, 13:00美東報價延遲15分鐘
5.16M總市值
虧損本益比TTM

Avalon Globocare Corp

1.260
-0.020-1.56%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.56%

5天

+41.99%

1月

-3.82%

6月

-56.22%

今年開始到現在

-61.35%

1年

-69.27%

查看詳細走勢圖

TradingKey Avalon Globocare Corp股票評分

單位: USD 更新時間: 2025-12-24

操作建議

Avalon Globocare Corp當前公司基本面數據相對謹慎,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名155/206位。機構持股佔比非常高,中期看,股價處於下降通道。近一個月,市場表現非常差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Avalon Globocare Corp評分

相關信息

行業排名
155 / 206
全市場排名
472 / 4562
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Avalon Globocare Corp亮點

亮點風險
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
業績增長期
公司處於發展階段,最新年度總收入1.33M美元
估值高估
公司最新PE估值-0.16,處於3年歷史高位
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉25.38K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.97

Avalon Globocare Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Avalon Globocare Corp簡介

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
公司代碼ALBT
公司Avalon Globocare Corp
CEOJin (David)
網址https://www.avalon-globocare.com/

常見問題

Avalon Globocare Corp(ALBT)的當前股價是多少?

Avalon Globocare Corp(ALBT)的當前股價是 1.260。

Avalon Globocare Corp 的股票代碼是什麼?

Avalon Globocare Corp的股票代碼是ALBT。

Avalon Globocare Corp股票的52週最高點是多少?

Avalon Globocare Corp股票的52週最高點是11.660。

Avalon Globocare Corp股票的52週最低點是多少?

Avalon Globocare Corp股票的52週最低點是0.878。

Avalon Globocare Corp的市值是多少?

Avalon Globocare Corp的市值是5.16M。

Avalon Globocare Corp的淨利潤是多少?

Avalon Globocare Corp的淨利潤為-7.90M。

現在Avalon Globocare Corp(ALBT)的股票是買入、持有還是賣出?

根據分析師評級,Avalon Globocare Corp(ALBT)的總體評級為--,目標價格為--。

Avalon Globocare Corp(ALBT)股票的每股收益(EPS TTM)是多少

Avalon Globocare Corp(ALBT)股票的每股收益(EPS TTM)是-8.090。
KeyAI